What are the clinical features of lysinuric protein intolerance?

Lysinuric Protein Intolerance: Clinical Features

Lysinuric protein intolerance (LPI) is a multisystemic inherited metabolic disorder characterized by protein intolerance, failure to thrive after weaning, hyperammonemia, and progressive complications involving the pulmonary, renal, hematological, and immune systems.

Core Clinical Presentation

Early Childhood Manifestations

The disease typically begins after weaning (around 9 months of age based on recent cohort data) with:

• Protein aversion and feeding intolerance - Patients spontaneously avoid protein-rich foods 1, 2
• Vomiting and refusal of feeding after protein intake 3
• Failure to thrive and growth retardation - Present in virtually all cases 4, 3
• Excessive drowsiness or somnolence following protein consumption or during infections 1, 5

Gastrointestinal and Hepatic Features

• Hepatosplenomegaly - A cardinal feature present in most patients 4, 3
• Severe diarrhea in some cases 2
• Mild transaminitis (AST/ALT 100-200 mg/dL range) 5

Neurological Complications

Hyperammonemic episodes manifest as 6, 4:

• Confusion, lethargy, and altered consciousness
• Hyperammonemic coma (potentially fatal)
• Psychomotor or intellectual retardation (in 5/7 patients in one series)
• Involuntary movements and disturbance of consciousness
• Neurodevelopmental delay

Critical pitfall: The neurological symptoms mirror those of urea cycle disorders, as LPI causes secondary urea cycle dysfunction due to intracellular trapping of arginine 3.

Hematological and Immunological Abnormalities

Blood Count Abnormalities

• Pancytopenia or isolated thrombocytopenia 1, 4
• Anemia as part of multi-lineage involvement

Life-Threatening Immune Complications

• Hemophagocytic lymphohistiocytosis (HLH) - Occurred in 4/7 patients in one pediatric series 4
• Macrophage activation syndrome 2, 7
• Combined immunodeficiency phenotype with:
  • Reduced B-cell and class-switched memory B-cell compartments
  • IgG deficiency
  • Impaired lymphocyte proliferative responses
  • Decreased IL-17 and IL-4 responses 8

Pulmonary Involvement

Pulmonary alveolar proteinosis (PAP) is a major prognostic factor and leading cause of death 9, 10, 4:

• Increasingly recognized complication
• Requires bronchoalveolar lavage for diagnosis and treatment 3
• May present with progressive respiratory symptoms
• The delTTCT1471 mutation (common in Tunisia) appears NOT associated with pulmonary involvement 4

Renal Disease

Renal involvement is a serious complication that may progress to end-stage kidney disease 1, 7:

Tubular Dysfunction

• Chronic tubulopathies (5/6 patients in French cohort) 7
• Mixed proteinuria with tubular dysfunction 1
• Elevated urinary lysine, ornithine, and arginine despite LOW plasma levels (diagnostic hallmark)

Glomerular Disease

• Membranoproliferative glomerulonephritis 7
• Unique case of evolution from polyclonal to monotypic immune glomerulonephritis (IgG1 kappa) 7
• Chronic kidney disease progression in 4/6 pediatric patients 7

Nephrologists should suspect LPI when encountering chronic kidney disease of unknown origin with mixed proteinuria and tubular dysfunction 1.

Musculoskeletal Manifestations

• Osteoporosis - Present in 3/7 patients in one series 4
• Muscle hypotonia 3
• Delayed growth - Universal finding 4

Metabolic and Laboratory Features

Biochemical Hallmarks

• Hyperammonemia - Present in all patients during acute episodes 4, 5
• Elevated urinary orotic acid - Consistent finding 4, 5
• Plasma amino acid pattern 5:
  • Elevated: glutamine, alanine, ornithine
  • Diminished: arginine, lysine
• Urine amino acids: Markedly elevated lysine, ornithine, arginine excretion 3

Additional Laboratory Abnormalities 1

• Hyperferritinemia
• Hypertriglyceridemia
• Elevated lactate dehydrogenase (LDH)
• Abnormally low serum urea levels (due to urea cycle dysfunction)

Clinical Variability and Diagnostic Challenges

Extreme phenotypic variability exists even within families 3, making diagnosis challenging:

• Some patients remain asymptomatic or minimally symptomatic if they spontaneously avoid protein 1, 2
• The elder sibling in one family had only mild symptoms due to protein aversion since toddler age, while the younger sibling (who preferred protein-rich foods) developed severe multi-organ disease 2
• Diagnosis is frequently delayed (median age 21 months despite symptom onset at 9 months) 4
• Blurred clinical signs may lead to missed diagnosis even into adulthood 1

Age-Related Presentation Patterns

Infants and Young Children

• Post-weaning protein intolerance dominates
• Growth failure is prominent
• Acute hyperammonemic crises

Older Children and Adults

• Chronic complications become apparent (pulmonary, renal)
• Some adults remain undiagnosed until incidental findings 1
• Progressive organ damage if untreated

The key to early diagnosis is recognizing the constellation of protein aversion, failure to thrive, hepatosplenomegaly, hematological abnormalities, and hyperammonemia in the appropriate clinical context 4, 3. Delays in diagnosis and treatment lead to irreversible long-term sequelae, particularly neurological and skeletal 4.